Nasdaq · Common stock
Akebia Therapeutics (AKBA)
$0.6438 +$0.08 (+13.57%)
- Day’s range
- $0.5765–$0.6754
- Volume
- 11.6M
AKBA price history
AKBA closed at $0.6438 on Oct. 26, 2026. Over the past year, its daily close ranged from $0.5622 on Oct. 22, 2026 to $3.17 on Oct. 27, 2025.
Data table: AKBA daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $0.6438 |
| Oct. 23, 2026 | $0.5669 |
| Oct. 22, 2026 | $0.5622 |
| Oct. 21, 2026 | $0.5853 |
| Oct. 20, 2026 | $0.6181 |
| Oct. 19, 2026 | $0.6801 |
| Oct. 16, 2026 | $0.6700 |
| Oct. 15, 2026 | $0.6955 |
| Oct. 14, 2026 | $0.7020 |
| Oct. 13, 2026 | $0.7700 |
| Oct. 12, 2026 | $0.7902 |
| Oct. 9, 2026 | $0.8011 |
| Oct. 8, 2026 | $0.8148 |
| Oct. 7, 2026 | $0.8734 |
| Oct. 6, 2026 | $0.8785 |
| Oct. 5, 2026 | $0.9105 |
| Oct. 2, 2026 | $0.8650 |
| Oct. 1, 2026 | $0.8710 |
| Sept. 30, 2026 | $0.9200 |
| Sept. 29, 2026 | $0.8861 |
| Sept. 28, 2026 | $0.8931 |
| Sept. 25, 2026 | $0.8962 |
| Sept. 24, 2026 | $0.9190 |
| Sept. 23, 2026 | $0.9326 |
| Sept. 22, 2026 | $0.9800 |
| Sept. 21, 2026 | $0.9385 |
| Sept. 18, 2026 | $0.9157 |
| Sept. 17, 2026 | $0.8955 |
| Sept. 16, 2026 | $0.9178 |
| Sept. 15, 2026 | $0.9030 |
| Sept. 14, 2026 | $0.9629 |
| Sept. 11, 2026 | $0.9517 |
| Sept. 10, 2026 | $0.9465 |
| Sept. 9, 2026 | $0.9539 |
| Sept. 8, 2026 | $1.03 |
| Sept. 4, 2026 | $0.9747 |
| Sept. 3, 2026 | $0.9833 |
| Sept. 2, 2026 | $0.9803 |
| Sept. 1, 2026 | $0.9447 |
| Aug. 31, 2026 | $0.9188 |
| Aug. 28, 2026 | $0.8786 |
| Aug. 27, 2026 | $0.9398 |
| Aug. 26, 2026 | $0.9065 |
| Aug. 25, 2026 | $0.9584 |
| Aug. 24, 2026 | $0.9006 |
| Aug. 21, 2026 | $0.9066 |
| Aug. 20, 2026 | $0.9194 |
| Aug. 19, 2026 | $0.8854 |
| Aug. 18, 2026 | $0.8518 |
| Aug. 17, 2026 | $0.8600 |
| Aug. 14, 2026 | $0.8728 |
| Aug. 13, 2026 | $0.8696 |
| Aug. 12, 2026 | $0.8932 |
| Aug. 11, 2026 | $0.8665 |
| Aug. 10, 2026 | $0.8440 |
| Aug. 7, 2026 | $0.9099 |
| Aug. 6, 2026 | $0.9544 |
| Aug. 5, 2026 | $1.29 |
| Aug. 4, 2026 | $1.32 |
| Aug. 3, 2026 | $1.31 |
| July 31, 2026 | $1.32 |
| July 30, 2026 | $1.35 |
| July 29, 2026 | $1.26 |
| July 28, 2026 | $1.27 |
| July 27, 2026 | $1.28 |
| July 24, 2026 | $1.22 |
| July 23, 2026 | $1.22 |
| July 22, 2026 | $1.26 |
| July 21, 2026 | $1.30 |
| July 20, 2026 | $1.28 |
| July 17, 2026 | $1.34 |
| July 16, 2026 | $1.40 |
| July 15, 2026 | $1.38 |
| July 14, 2026 | $1.40 |
| July 13, 2026 | $1.38 |
| July 10, 2026 | $1.40 |
| July 9, 2026 | $1.43 |
| July 8, 2026 | $1.42 |
| July 7, 2026 | $1.36 |
| July 6, 2026 | $1.30 |
| July 2, 2026 | $1.24 |
| July 1, 2026 | $1.21 |
| June 30, 2026 | $1.14 |
| June 29, 2026 | $1.11 |
| June 26, 2026 | $1.14 |
| June 25, 2026 | $1.04 |
| June 24, 2026 | $1.06 |
| June 23, 2026 | $1.10 |
| June 22, 2026 | $1.09 |
| June 18, 2026 | $1.07 |
| June 17, 2026 | $1.02 |
| June 16, 2026 | $0.9840 |
| June 15, 2026 | $0.9387 |
| June 12, 2026 | $0.9245 |
| June 11, 2026 | $0.8994 |
| June 10, 2026 | $0.8729 |
| June 9, 2026 | $0.9200 |
| June 8, 2026 | $0.9356 |
| June 5, 2026 | $0.9353 |
| June 4, 2026 | $0.9703 |
| June 3, 2026 | $0.9697 |
| June 2, 2026 | $0.9364 |
| June 1, 2026 | $1.02 |
| May 29, 2026 | $1.02 |
| May 28, 2026 | $1.05 |
| May 27, 2026 | $1.03 |
| May 26, 2026 | $1.04 |
| May 22, 2026 | $1.02 |
| May 21, 2026 | $1.02 |
| May 20, 2026 | $1.01 |
| May 19, 2026 | $0.8951 |
| May 18, 2026 | $1.01 |
| May 15, 2026 | $1.06 |
| May 14, 2026 | $1.13 |
| May 13, 2026 | $1.18 |
| May 12, 2026 | $1.18 |
| May 11, 2026 | $1.15 |
| May 8, 2026 | $1.16 |
| May 7, 2026 | $1.18 |
| May 6, 2026 | $1.48 |
| May 5, 2026 | $1.45 |
| May 4, 2026 | $1.50 |
| May 1, 2026 | $1.40 |
| April 30, 2026 | $1.38 |
| April 29, 2026 | $1.36 |
| April 28, 2026 | $1.42 |
| April 27, 2026 | $1.42 |
| April 24, 2026 | $1.43 |
| April 23, 2026 | $1.43 |
| April 22, 2026 | $1.42 |
| April 21, 2026 | $1.41 |
| April 20, 2026 | $1.43 |
| April 17, 2026 | $1.41 |
| April 16, 2026 | $1.35 |
| April 15, 2026 | $1.55 |
| April 14, 2026 | $1.56 |
| April 13, 2026 | $1.47 |
| April 10, 2026 | $1.40 |
| April 9, 2026 | $1.41 |
| April 8, 2026 | $1.43 |
| April 7, 2026 | $1.38 |
| April 6, 2026 | $1.32 |
| April 2, 2026 | $1.38 |
| April 1, 2026 | $1.41 |
| March 31, 2026 | $1.39 |
| March 30, 2026 | $1.32 |
| March 27, 2026 | $1.34 |
| March 26, 2026 | $1.39 |
| March 25, 2026 | $1.39 |
| March 24, 2026 | $1.36 |
| March 23, 2026 | $1.40 |
| March 20, 2026 | $1.42 |
| March 19, 2026 | $1.42 |
| March 18, 2026 | $1.44 |
| March 17, 2026 | $1.49 |
| March 16, 2026 | $1.51 |
| March 13, 2026 | $1.46 |
| March 12, 2026 | $1.40 |
| March 11, 2026 | $1.40 |
| March 10, 2026 | $1.38 |
| March 9, 2026 | $1.35 |
| March 6, 2026 | $1.27 |
| March 5, 2026 | $1.19 |
| March 4, 2026 | $1.25 |
| March 3, 2026 | $1.22 |
| March 2, 2026 | $1.26 |
| Feb. 27, 2026 | $1.31 |
| Feb. 26, 2026 | $1.32 |
| Feb. 25, 2026 | $1.21 |
| Feb. 24, 2026 | $1.24 |
| Feb. 23, 2026 | $1.21 |
| Feb. 20, 2026 | $1.18 |
| Feb. 19, 2026 | $1.18 |
| Feb. 18, 2026 | $1.18 |
| Feb. 17, 2026 | $1.20 |
| Feb. 13, 2026 | $1.21 |
| Feb. 12, 2026 | $1.36 |
| Feb. 11, 2026 | $1.55 |
| Feb. 10, 2026 | $1.51 |
| Feb. 9, 2026 | $1.50 |
| Feb. 6, 2026 | $1.39 |
| Feb. 5, 2026 | $1.38 |
| Feb. 4, 2026 | $1.37 |
| Feb. 3, 2026 | $1.41 |
| Feb. 2, 2026 | $1.38 |
| Jan. 30, 2026 | $1.41 |
| Jan. 29, 2026 | $1.45 |
| Jan. 28, 2026 | $1.45 |
| Jan. 27, 2026 | $1.51 |
| Jan. 26, 2026 | $1.43 |
| Jan. 23, 2026 | $1.36 |
| Jan. 22, 2026 | $1.44 |
| Jan. 21, 2026 | $1.37 |
| Jan. 20, 2026 | $1.34 |
| Jan. 16, 2026 | $1.36 |
| Jan. 15, 2026 | $1.34 |
| Jan. 14, 2026 | $1.38 |
| Jan. 13, 2026 | $1.38 |
| Jan. 12, 2026 | $1.40 |
| Jan. 9, 2026 | $1.52 |
| Jan. 8, 2026 | $1.49 |
| Jan. 7, 2026 | $1.53 |
| Jan. 6, 2026 | $1.47 |
| Jan. 5, 2026 | $1.51 |
| Jan. 2, 2026 | $1.55 |
| Dec. 31, 2025 | $1.61 |
| Dec. 30, 2025 | $1.59 |
| Dec. 29, 2025 | $1.62 |
| Dec. 26, 2025 | $1.66 |
| Dec. 24, 2025 | $1.70 |
| Dec. 23, 2025 | $1.65 |
| Dec. 22, 2025 | $1.66 |
| Dec. 19, 2025 | $1.66 |
| Dec. 18, 2025 | $1.67 |
| Dec. 17, 2025 | $1.61 |
| Dec. 16, 2025 | $1.62 |
| Dec. 15, 2025 | $1.61 |
| Dec. 12, 2025 | $1.66 |
| Dec. 11, 2025 | $1.66 |
| Dec. 10, 2025 | $1.63 |
| Dec. 9, 2025 | $1.58 |
| Dec. 8, 2025 | $1.62 |
| Dec. 5, 2025 | $1.54 |
| Dec. 4, 2025 | $1.59 |
| Dec. 3, 2025 | $1.57 |
| Dec. 2, 2025 | $1.47 |
| Dec. 1, 2025 | $1.51 |
| Nov. 28, 2025 | $1.58 |
| Nov. 26, 2025 | $1.59 |
| Nov. 25, 2025 | $1.57 |
| Nov. 24, 2025 | $1.59 |
| Nov. 21, 2025 | $1.55 |
| Nov. 20, 2025 | $1.54 |
| Nov. 19, 2025 | $1.59 |
| Nov. 18, 2025 | $1.65 |
| Nov. 17, 2025 | $1.76 |
| Nov. 14, 2025 | $1.67 |
| Nov. 13, 2025 | $1.76 |
| Nov. 12, 2025 | $1.85 |
| Nov. 11, 2025 | $1.81 |
| Nov. 10, 2025 | $1.67 |
| Nov. 7, 2025 | $2.04 |
| Nov. 6, 2025 | $2.01 |
| Nov. 5, 2025 | $2.12 |
| Nov. 4, 2025 | $2.09 |
| Nov. 3, 2025 | $2.12 |
| Oct. 31, 2025 | $2.21 |
| Oct. 30, 2025 | $2.10 |
| Oct. 29, 2025 | $2.10 |
| Oct. 28, 2025 | $3.09 |
| Oct. 27, 2025 | $3.17 |
Key figures
- 52-week range
- $0.5622–$3.17Low Oct. 22, 2026; high Oct. 27, 2025
- Average daily volume
- 7.8MPast 3 months
- Market value
- $178.4M
- Dividend yield
- —
- From 52-week high
- −79.69%
Price change
- 1 month
- −28.16%
- 3 months
- −47.23%
- Year to date
- −60.01%
- 1 year
- −78.75%
$1,000 a year ago
$1,000 put into AKBA at the close on Oct. 24, 2025 would be worth $212.
Price only, dividends not included.
What Wall Street says about AKBA
In the past 90 days, Wall Street firms published 3 rating or price-target actions on AKBA: 1 downgrade, 1 new rating and 1 reiterated rating.
| Action | Rating | |||
|---|---|---|---|---|
| BTIG | Reiterates | Buy | $4 | |
| WestPark Capital | Initiates coverage | Buy | $4.50 | |
| Leerink Partners | Downgrade | Outperform to Market perform | $1 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About Akebia Therapeutics, Inc.
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.
- Headquarters
- Cambridge, Mass.
- Employees
- 194
- Listed
- March 20, 2014
- Sector
- Health care
- Industry
- Pharmaceutical preparations
In WallStreetDigest editions
No WallStreetDigest article about AKBA is on the site yet.